लोड हो रहा है...
Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responses in Vitro and in Vivo
HER-2 is a member of the EGF receptor family and is overexpressed in 20–30% of breast cancers. HER-2 overexpression causes increased expression of VEGF at both the RNA and protein levels. HER-2 and VEGF are therefore considered good targets for cancer treatment, which has led to the development of t...
में बचाया:
मुख्य लेखकों: | , , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
American Society for Biochemistry and Molecular Biology
2011
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3075707/ https://ncbi.nlm.nih.gov/pubmed/21325276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M110.216820 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|